Kaiser, Thomas Maxwell (2013-11-11)
Pharmaceutical R&D is currently undergoing a productivity crisis. Also, the loss of activity of established medicines continues to reduce the pool of agents capable of treating infectious diseases. Small molecule synthesis ...